{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:52:06Z","timestamp":1778953926776,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHR 168846"],"award-info":[{"award-number":["CIHR 168846"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.dmd.2025.100077","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T11:06:51Z","timestamp":1743592011000},"page":"100077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sex-dependent alterations in cardiac cytochrome P450-mediated arachidonic acid metabolism in pressure overload\u2013induced cardiac hypertrophy in rats"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0450-0056","authenticated-orcid":false,"given":"Samar H.","family":"Gerges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9830-8323","authenticated-orcid":false,"given":"Heidi L.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason R.B.","family":"Dyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-0400","authenticated-orcid":false,"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2025.100077_bib1","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1476-5381.2009.00461.x","article-title":"3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats","volume":"158","author":"Aboutabl","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dmd.2025.100077_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/dmd.115.063776","article-title":"Early changes in cytochrome P450s and their associated arachidonic acid metabolites play a crucial role in the initiation of cardiac hypertrophy induced by isoproterenol","volume":"43","author":"Althurwi","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100077_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120965752","article-title":"Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer","volume":"8","author":"Amin","year":"2020","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.dmd.2025.100077_bib5","first-page":"135","article-title":"Eicosanoid profiling in effluent of isolated perfused heart of Tg\u03b1q\u221744 mice with advanced heart failure","volume":"70","author":"Berkowicz","year":"2019","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.echo.2015.05.007","article-title":"A summary of the American Society of Echocardiography Foundation value-based healthcare: summit 2014: the role of cardiovascular ultrasound in the new paradigm","volume":"28","author":"Byrd","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.dmd.2025.100077_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/138920009787522188","article-title":"Stereoselectivity in drug metabolism: molecular mechanisms and analytical methods","volume":"10","author":"Campo","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.dmd.2025.100077_bib8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/iub.241","article-title":"Cytochrome P450 enzymes and the heart","volume":"61","author":"Chaudhary","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.dmd.2025.100077_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/aja.aja_80_20","article-title":"Testosterone, cardiomyopathies, and heart failure: a narrative review","volume":"23","author":"Diaconu","year":"2021","journal-title":"Asian J Androl"},{"key":"10.1016\/j.dmd.2025.100077_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/hmbci-2013-0048","article-title":"Sex hormones in the cardiovascular system","volume":"18","author":"dos Santos","year":"2014","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.dmd.2025.100077_bib11","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","article-title":"Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association","volume":"142","author":"El Khoudary","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.dmd.2025.100077_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pharmthera.2005.05.011","article-title":"Cytochrome P450 enzymes: central players in cardiovascular health and disease","volume":"112","author":"Elbekai","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100077_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.taap.2015.10.003","article-title":"19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy","volume":"289","author":"Elkhatali","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/FJC.0000000000000494","article-title":"Inhibition of mid-chain HETEs protects against angiotensin II-induced cardiac hypertrophy","volume":"70","author":"Elkhatali","year":"2017","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1139\/cjpp-2024-0037","article-title":"Cytochrome P450 1B1 is critical in the development of TNF-\u03b1, IL-6, and LPS-induced cellular hypertrophy","volume":"102","author":"ElKhatib","year":"2024","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/03602532.2022.2162075","article-title":"Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy","volume":"55","author":"ElKhatib","year":"2023","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmd.2025.100077_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3109\/00498254.2015.1032385","article-title":"Modulation of aryl hydrocarbon receptor regulated genes by acute administration of trimethylarsine oxide in the lung, kidney and heart of C57BL\/6 mice","volume":"45","author":"Elshenawy","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmd.2025.100077_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bcp.2013.11.015","article-title":"Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy","volume":"87","author":"El-Sherbeni","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2016.1257021","article-title":"Microsomal cytochrome P450 as a target for drug discovery and repurposing","volume":"49","author":"El-Sherbeni","year":"2017","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmd.2025.100077_bib20","doi-asserted-by":"crossref","first-page":"R1597","DOI":"10.1152\/ajpregu.00825.2009","article-title":"Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload","volume":"298","author":"Fliegner","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.dmd.2025.100077_bib21","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.4049\/jimmunol.178.11.6710","article-title":"Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease","volume":"178","author":"Frisancho-Kiss","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.dmd.2025.100077_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108046","article-title":"Sex differences in eicosanoid formation and metabolism: a possible mediator of sex discrepancies in cardiovascular diseases","volume":"234","author":"Gerges","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100077_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/dmd.122.000915","article-title":"Sexual dimorphism in the expression of cytochrome P450 enzymes in rat heart, liver, kidney, lung, brain, and small intestine","volume":"51","author":"Gerges","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100077_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1139\/cjpp-2023-0014","article-title":"Sex- and enantiospecific differences in the formation rate of hydroxyeicosatetraenoic acids in rat organs","volume":"101","author":"Gerges","year":"2023","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1438567","article-title":"11-Hydroxyeicosatetraenoics induces cellular hypertrophy in an enantioselective manner","volume":"15","author":"Helal","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s13318-023-00857-1","article-title":"The effects of 16-HETE enantiomers on hypertrophic markers in human fetal ventricular cardiomyocytes, RL-14 cells","volume":"48","author":"Hidayat","year":"2023","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100077_bib27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s11010-023-04801-4","article-title":"16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism","volume":"479","author":"Hidayat","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.dmd.2025.100077_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2022.106701","article-title":"The enantioselective separation and quantitation of the hydroxy-metabolites of arachidonic acid by liquid chromatography\u2014tandem mass spectrometry","volume":"165","author":"Isse","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.dmd.2025.100077_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106749","article-title":"17-(R\/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enantioselective manners","volume":"168","author":"Isse","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.dmd.2025.100077_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvn346","article-title":"Eicosanoid signalling pathways in the heart","volume":"82","author":"Jenkins","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.dmd.2025.100077_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1172\/JCI9307","article-title":"Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression","volume":"106","author":"Kadokami","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dmd.2025.100077_bib32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1152\/physiolgenomics.00199.2010","article-title":"Role of the estrogen\/estrogen-receptor-beta axis in the genomic response to pressure overload-induced hypertrophy","volume":"43","author":"Kararigas","year":"2011","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.dmd.2025.100077_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13293-019-0223-0","article-title":"Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease","volume":"10","author":"Kessler","year":"2019","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.dmd.2025.100077_bib34","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1007\/s11357-024-01160-w","article-title":"Sex-specific cardiovascular remodeling leads to a divergent sex-dependent development of heart failure in aged hypertensive rats","volume":"46","author":"Kov\u00e1cs","year":"2024","journal-title":"GeroScience"},{"key":"10.1016\/j.dmd.2025.100077_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00041433-200206000-00007","article-title":"Cytochrome P450 pathways of arachidonic acid metabolism","volume":"13","author":"Kroetz","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.dmd.2025.100077_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.642470","article-title":"The role of epoxyeicosatrienoic acids in cardiac remodeling","volume":"12","author":"Lai","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.dmd.2025.100077_bib37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3109\/13880209.2013.877038","article-title":"Oral sophocarpine protects rat heart against pressure overload-induced cardiac fibrosis","volume":"52","author":"Li","year":"2014","journal-title":"Pharm Biol"},{"key":"10.1016\/j.dmd.2025.100077_bib38","article-title":"Innate immune cells in pressure overload-induced cardiac hypertrophy and remodeling","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.dmd.2025.100077_bib39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.dmd.2025.100077_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dmd.2025.100077_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00204-014-1419-z","article-title":"5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-\u03baB-dependent mechanism","volume":"90","author":"Maayah","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.dmd.2025.100077_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00204-015-1620-8","article-title":"The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy","volume":"90","author":"Maayah","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.dmd.2025.100077_bib43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10565-015-9308-7","article-title":"Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-\u03baB","volume":"31","author":"Maayah","year":"2015","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.dmd.2025.100077_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.phrs.2015.12.016","article-title":"CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism","volume":"105","author":"Maayah","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dmd.2025.100077_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11010-017-2943-y","article-title":"The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol","volume":"429","author":"Maayah","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.dmd.2025.100077_bib46","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1038\/s41598-018-20613-9","article-title":"2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy","volume":"8","author":"Maayah","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmd.2025.100077_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yjmcc.2018.10.023","article-title":"Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites","volume":"125","author":"Matsumura","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.dmd.2025.100077_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112154","article-title":"Tongsaimai reverses the hypertension and left ventricular remolding caused by abdominal aortic constriction in rats","volume":"246","author":"Meng","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib49","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.968792","article-title":"Sex\/gender differences in cardiovascular disease prevention: what a difference a decade makes","volume":"124","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.dmd.2025.100077_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.dmd.2025.100077_bib51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/FJC.0000000000001013","article-title":"Unraveling the role of 12- and 20- HETE in cardiac pathophysiology: G-protein-coupled receptors, pharmacological inhibitors, and transgenic approaches","volume":"77","author":"Pascale","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib52","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/en.2008-0133","article-title":"Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin","volume":"149","author":"Pedram","year":"2008","journal-title":"Endocrinology"},{"issue":"11 Suppl","key":"10.1016\/j.dmd.2025.100077_bib53","first-page":"S23","article-title":"Regression of myocardial hypertrophy after aortic valve replacement: faster in women?","volume":"122","author":"Petrov","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.dmd.2025.100077_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00021.2015","article-title":"Mechanistic pathways of sex differences in cardiovascular disease","volume":"97","author":"Regitz-Zagrosek","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.dmd.2025.100077_bib55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.07.004","article-title":"20-HETE in the regulation of vascular and cardiac function","volume":"192","author":"Rocic","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"10 Suppl","key":"10.1016\/j.dmd.2025.100077_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13697130601114917","article-title":"Menopause and cardiovascular disease: the evidence","volume":"10","author":"Rosano","year":"2007","journal-title":"Climacteric"},{"key":"10.1016\/j.dmd.2025.100077_bib57","doi-asserted-by":"crossref","first-page":"H502","DOI":"10.1152\/ajpheart.00202.2018","article-title":"Pressure-volume analysis reveals characteristic sex-related differences in cardiac function in a rat model of aortic banding-induced myocardial hypertrophy","volume":"315","author":"Ruppert","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.dmd.2025.100077_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148769","article-title":"Sex-related differences in hypertrophy response and cardiac expression of G protein-coupled estrogen receptor in rats with pressure overload","volume":"928","author":"Salehiyeh","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.dmd.2025.100077_bib59","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171496","article-title":"20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats","volume":"38","author":"Sedl\u00e1kov\u00e1","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.dmd.2025.100077_bib60","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/cfr.2023.05","article-title":"Global public health burden of heart failure: an updated review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.dmd.2025.100077_bib61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.dmd.2025.100077_bib62","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1124\/dmd.118.082073","article-title":"S-Enantiomer of 19-hydroxyeicosatetraenoic acid preferentially protects against angiotensin II-induced cardiac hypertrophy","volume":"46","author":"Shoieb","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100077_bib63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11010-020-03777-9","article-title":"Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites","volume":"471","author":"Shoieb","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.dmd.2025.100077_bib64","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/FJC.0000000000001258","article-title":"Ameliorative role of fluconazole against abdominal aortic constriction-induced cardiac hypertrophy in rats","volume":"79","author":"Shoieb","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib65","doi-asserted-by":"crossref","first-page":"H469","DOI":"10.1152\/ajpheart.00723.2004","article-title":"Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy","volume":"288","author":"Skavdahl","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.dmd.2025.100077_bib66","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.dmd.2025.100077_bib67","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FJC.0000000000000410","article-title":"Inhibition of TNF-\u03b1-mediated NF-\u03baB activation by ginsenoside Rg1 contributes the attenuation of cardiac hypertrophy induced by abdominal aorta coarctation","volume":"68","author":"Tang","year":"2016","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib68","doi-asserted-by":"crossref","first-page":"E365","DOI":"10.9778\/cmajo.20150130","article-title":"The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis","volume":"4","author":"Tran","year":"2016","journal-title":"CMAJ Open"},{"key":"10.1016\/j.dmd.2025.100077_bib69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.vph.2013.02.004","article-title":"Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line","volume":"58","author":"Tse","year":"2013","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib70","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prostaglandins.2016.05.007","article-title":"The role of 20-HETE in cardiovascular diseases and its risk factors","volume":"125","author":"Waldman","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.dmd.2025.100077_bib71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-16009-2_6","article-title":"Cytochrome p450 enzymes in the bioactivation of polyunsaturated fatty acids and their role in cardiovascular disease","volume":"851","author":"Westphal","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.dmd.2025.100077_bib72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bcp.12603","article-title":"The role of epoxyeicosatrienoic acids in the cardiovascular system","volume":"80","author":"Yang","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100077_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113326","article-title":"Epoxyeicosatrienoic acid: a potential therapeutic target of heart failure with preserved ejection fraction","volume":"153","author":"Zhang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.dmd.2025.100077_bib74","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1124\/dmd.108.023077","article-title":"Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats","volume":"36","author":"Zordoky","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100077_bib75","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138920008783571792","article-title":"Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure","volume":"9","author":"Zordoky","year":"2008","journal-title":"Curr Drug Metab"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625090865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625090865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:03:12Z","timestamp":1778634192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625090865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0090955625090865"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100077","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-dependent alterations in cardiac cytochrome P450-mediated arachidonic acid metabolism in pressure overload\u2013induced cardiac hypertrophy in rats","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100077"}}